CHC — Investor Presentation 2019

Nov 28, 2019

==> picture [594 x 127] intentionally omitted <==

==> picture [128 x 127] intentionally omitted <==

==> picture [452 x 57] intentionally omitted <==

Investor Conference 4164 TT

Nov 29, 2019

==> picture [159 x 51] intentionally omitted <==

Dual ISO Certifications

==> picture [107 x 102] intentionally omitted <==

ISO 9001 Quality Management Systems

==> picture [99 x 96] intentionally omitted <==

OHSAS 18001 Occupational Health and Safety Management Certification

==> picture [144 x 33] intentionally omitted <==

2

Disclaimer

• The information contained in this confidential document ("Presentation") has been prepared by CHC Healthcare Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment.

• While the information contained herein has been prepared in good faith, neither the Company nor any of its shareholders, directors, officers, agents, employees or advisers give, have given or have authority to give, any representations or warranties (express or implied) as to, or in relation to, the accuracy, reliability or completeness of the information in this Presentation, or any revision thereof, or of any other written or oral information made or to be made available to any interested party or its advisers (all such information being referred to as "Information") and liability therefore is expressly disclaimed. Accordingly, neither the Company nor any of its shareholders, directors, officers, agents, employees or advisers take any responsibility for, or will accept any liability whether direct or indirect, express or implied, contractual, tortious, statutory or otherwise, in respect of, the accuracy or completeness of the Information or for any of the opinions contained herein or for any errors, omissions or misstatements or for any loss, howsoever arising, from the use of this Presentation.

• Neither the issue of this Presentation nor any part of its contents is to be taken as any form of commitment on the part of the Company to proceed with any transaction and the right is reserved to terminate any discussions or negotiations with any prospective investors. In no circumstances will the Company be responsible for any costs, losses or expenses incurred in connection with any appraisal or investigation of the Company. In furnishing this Presentation, the Company does not undertake or agree to any obligation to provide the recipient with access to any additional information or to update this Presentation or to correct any inaccuracies in, or omissions from, this Presentation which may become apparent.

• This Presentation should not be considered as the giving of investment advice by the Company or any of its shareholders, directors, officers, agents, employees or advisers. Each party to whom this Presentation is made available must make its own independent assessment of the Company after making such investigations and taking such advice as may be deemed necessary. In particular, any estimates or projections or opinions contained herein necessarily involve significant elements of subjective judgment, analysis and assumptions and each recipient should satisfy itself in relation to such matters.

• This Presentation includes certain statements that may be deemed “forward-looking statements”. All statements in this discussion, other than statements of historical facts, that address future activities and events or developments that the Company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially from those projected in forward-looking statements.

3

==> picture [594 x 124] intentionally omitted <==

==> picture [128 x 124] intentionally omitted <==

==> picture [586 x 236] intentionally omitted <==

----- Start of picture text -----

Company Smart Health
Introduction Health Care
----- End of picture text -----

==> picture [144 x 33] intentionally omitted <==

4

==> picture [594 x 124] intentionally omitted <==

==> picture [128 x 124] intentionally omitted <==

==> picture [586 x 236] intentionally omitted <==

----- Start of picture text -----

Company Smart Health
Introduction Health Care
----- End of picture text -----

==> picture [144 x 33] intentionally omitted <==

5

Company Introduction

• Name： CHC Healthcare Group (4164 TT)

• Date of establishment： 2009/11/27

(First subsidiary, Chiu Ho Instruments & Reagent, was founded in 1977)

• President： Mr. Pei-Lin, Lee

• Headquarters： Taipei

• Branches： Taichung, Kaohsiung, Beijing, Guangzhou & Jakarta

• Major business： Medical equipment direct selling,

• Medical management service

• Paid-in capital： NT$ 1,416,335,390

• Listing date： 2012/10/24

==> picture [144 x 33] intentionally omitted <==

6

Business Model

==> picture [720 x 282] intentionally omitted <==

----- Start of picture text -----

Manufacturer
Medical
Direct
CHC Management
Selling
Service
Hospital & Clinic
----- End of picture text -----

==> picture [144 x 33] intentionally omitted <==

7

Annually Operating Revenue - 2015~2019

==> picture [720 x 284] intentionally omitted <==

----- Start of picture text -----

(NT$ thousand)
3,000,000
2,507,466 2,493,639
2,395,331
2,500,000
2,205,206
2,117,116
2,000,000
1,500,000
1,000,000
500,000
-
2015 2016 2017 2018 2019 Jan to Oct
----- End of picture text -----

==> picture [144 x 33] intentionally omitted <==

8

Profitability - 2015~2019

==> picture [720 x 326] intentionally omitted <==

----- Start of picture text -----

(NT$ thousand) (NT$)
400,000 4
3.5
317,829 313,759
300,000 3
222,687 2.32 2.5
2.28
200,000 2
1.73 160,604
1.5
1.14
100,000 1
0.5
-89,286
0 0
-0.62 -0.5
-100,000 -1
2015 2016 2017 2018 2019 Q1-Q3
Profit for the period Basic EPS
9
----- End of picture text -----

Earnings Distribution & Dividend Yield - 2014~2018

(NT$) 0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 10% 0 0.5 1 1.5 2 2.5 2014 2015 2016 2017 2018 Cash dividends per share Dividend yield	Cash dividends per share (NT$) Average closing price for the year Dividend yield 2014 2 72.86 3% 2015 2.004 56.22 4% 2016 1.004 49.68 2% 2017 1.1 40.69 3% 2018 1.8 33.87 5%

==> picture [144 x 33] intentionally omitted <==

10

==> picture [594 x 124] intentionally omitted <==

==> picture [128 x 124] intentionally omitted <==

==> picture [409 x 236] intentionally omitted <==

----- Start of picture text -----

Smart Health
Health Care
----- End of picture text -----

==> picture [144 x 33] intentionally omitted <==

11

Elekta Linear Accelerator

Versatile, all-in-one radiotherapy system

･ ･ Versa HD™ – Precise Intelligent Quality Assured

==> picture [144 x 33] intentionally omitted <==

12

Elekta Linear Accelerator

==> picture [488 x 271] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

13

Elekta MR-Linac

==> picture [720 x 252] intentionally omitted <==

Unity – Two worlds, one future

==> picture [144 x 33] intentionally omitted <==

14

Elekta MR-Linac

==> picture [503 x 278] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

15

Elekta MR-Linac

“We needed online, real-time, diagnostic quality MR imaging within the treatment workflow. Elekta Unity is the only system that can provide this.” Professor Dr Daniel Zips, Medical Director, CCC Tübingen-Stuttgart, Germany

==> picture [379 x 259] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

16

IBA Proton Therapy

==> picture [94 x 68] intentionally omitted <==

30+ 50+ 65%+ YEARS OF EXPERIENCE CENTERS IN OPERATION / DEVELOPMENT PATIENTS TREATED WITH IBA

==> picture [144 x 33] intentionally omitted <==

17

IBA Proton Therapy

==> picture [94 x 68] intentionally omitted <==

==> picture [515 x 248] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

18

IBA Proton Therapy

==> picture [94 x 68] intentionally omitted <==

==> picture [519 x 290] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

19

IBA Proton Therapy

==> picture [94 x 68] intentionally omitted <==

< Pencil Beam Scanning by IBA >

==> picture [720 x 174] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

20

IBA Proton Therapy

==> picture [94 x 68] intentionally omitted <==

Think Big, Scale Smart

S2C2: next generation cyclotron design Only compact solution with IMPT Equip with Pencil Beam Scanning Efficient workflow and operations

==> picture [144 x 33] intentionally omitted <==

ProteusONE

21

IMRIS Hybrid Surgical Theatre

==> picture [720 x 309] intentionally omitted <==

22

IMRIS Hybrid Surgical Theatre

==> picture [144 x 33] intentionally omitted <==

23

Hill-Rom Robotic OR

Redefining Patient Positioning in da Vinci[®] Surgery

==> picture [144 x 33] intentionally omitted <==

24

Hill-Rom Robotic OR

==> picture [88 x 89] intentionally omitted <==

==> picture [88 x 88] intentionally omitted <==

==> picture [88 x 89] intentionally omitted <==

Wireless Connectivity

Robust connection to the da Vinci[®] Xi™ and long battery life to reduce clutter in the OR

Trumpf Medical dV Remote Control Easy-to-use remote guides OR team through setup and intraoperative use, providing precise table angles to the entire OR team.

Range of Motion & Weight Limit Wide range of motion: ± 45 ° trend | ± 30 ° tilt. 23 in ( ± 0.4 in) [59 cm ( ± 1 cm)] minimum height. Maximum patient weight of 450 kg.

==> picture [270 x 296] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

25

==> picture [594 x 124] intentionally omitted <==

==> picture [128 x 124] intentionally omitted <==

==> picture [231 x 236] intentionally omitted <==

----- Start of picture text -----

Company
Introduction
----- End of picture text -----

==> picture [231 x 236] intentionally omitted <==

----- Start of picture text -----

Health
Care
----- End of picture text -----

==> picture [144 x 33] intentionally omitted <==

26

World Aging Trend

	Year when ageing status changed	Year when ageing status changed	Year when ageing status changed	Speed of population ageing (Year)	Speed of population ageing (Year)
	Ageing Society (7%)	Aged Society (14%)	Super-Aged society (20%)	7% to 14%	14% to 20%
**Taiwan **	1993	2018	2026(e)	25	8(e)
Japan	1970	1994	2005	24	11
South Korea	1999	2017	2026(e)	18	9(e)
Singapore	1999	2019(e)	2026(e)	20(e)	7(e)
United States	1942	2013	2028(e)	71	15(e)
Canada	1945	2010	2024(e)	65	14(e)
United Kingdom	1929	1976	2027(e)	47	51(e)
Germany	1932	1972	2008	40	36
Norway	1885	1977	2036(e)	92	59(e)
Australia	1939	2011	2034(e)	72	22(e)

*Source: National Development Council

==> picture [144 x 33] intentionally omitted <==

27

Cyberdyne HAL®

==> picture [467 x 285] intentionally omitted <==

==> picture [118 x 69] intentionally omitted <==

==> picture [210 x 137] intentionally omitted <==

==> picture [210 x 146] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

28

Cyberdyne HAL®

==> picture [118 x 69] intentionally omitted <==

==> picture [187 x 172] intentionally omitted <==

==> picture [474 x 286] intentionally omitted <==

==> picture [187 x 116] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

29

Cyberdyne HAL®

==> picture [224 x 299] intentionally omitted <==

==> picture [267 x 337] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

30

Cyberdyne HAL®

==> picture [214 x 104] intentionally omitted <==

==> picture [210 x 110] intentionally omitted <==

==> picture [210 x 114] intentionally omitted <==

==> picture [134 x 351] intentionally omitted <==

==> picture [118 x 69] intentionally omitted <==

==> picture [214 x 111] intentionally omitted <==

==> picture [215 x 100] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

31

Cyberdyne HAL®

==> picture [118 x 69] intentionally omitted <==

==> picture [483 x 271] intentionally omitted <==

*Source: Great Big Story, Youtube

==> picture [144 x 33] intentionally omitted <==

32

Market Information of Elderly Care Industry

33	• Market Gapin Taiwan	• Market Gapin Taiwan	• Market Gapin Taiwan
	The Dependent Elderly
		Capacity	Demand	Market Gap
				Amount	%
	Institution for physical incapacity	105,066	421,800	316,734	75%
	Institution for mental incapacity	1,291	155,100	153,809	99%
	The Independent Elderly
		Capacity	Demand	Market Gap
				Amount	%
	Elderly housing for the healthy and sub-healthy elderly	15,214	2,744,900	2,729,686	99%
	*Source: Ministry of the Interior; Ministry of Health and Welfare

33

Partnership with Sakurajyuji Group

==> picture [362 x 164] intentionally omitted <==

==> picture [273 x 25] intentionally omitted <==

==> picture [94 x 24] intentionally omitted <==

==> picture [76 x 23] intentionally omitted <==

==> picture [720 x 157] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

34

Enter Elderly Care Market with New Perspective

==> picture [451 x 240] intentionally omitted <==

==> picture [270 x 181] intentionally omitted <==

==> picture [270 x 140] intentionally omitted <==

• Aging in Place • Preventive Medicine • Continuing Care

==> picture [94 x 36] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

35

==> picture [164 x 108] intentionally omitted <==

==> picture [319 x 104] intentionally omitted <==

==> picture [193 x 103] intentionally omitted <==

==> picture [291 x 107] intentionally omitted <==

==> picture [161 x 102] intentionally omitted <==

Thank you

==> picture [70 x 104] intentionally omitted <==

==> picture [101 x 102] intentionally omitted <==

==> picture [170 x 114] intentionally omitted <==

==> picture [69 x 103] intentionally omitted <==

==> picture [142 x 103] intentionally omitted <==

==> picture [118 x 101] intentionally omitted <==

==> picture [144 x 33] intentionally omitted <==

36